RAP 0.00% 20.5¢ raptor resources limited

Ann: Trading Halt, page-123

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. Dhm
    2,389 Posts.
    lightbulb Created with Sketch. 3507
    Once again this is the time to stay calm, remind ourselves about how we have got to this point in time and the amazing opportunity we have.
    - we have CE Mark for both adults and children on the back of very accurate clinical testing.
    - On the back of CE, we have TGA for adults and children.
    - No one else does this technology, anywhere, and it will remain that way because Professor Abeyratne and his team have been collecting and tweaking the AI for over 10 years. Imitators will need 10 years of catching up.
    - The world is on it's knees calling out for respiratory diagnosis, and we have it. Here and now.
    - The FDA is encouraging fast track approval on respiratory devices.
    - The Chinese NMPA are also calling for fast tracking of respiratory devices
    - RAP senior management as far back as a week or more ago have acknowledged the Chinese fast tracking but couldn't add any more to their comment other than "we are aware of the opportunity"

    Based on all this I cannot believe there can be anything than a positive result for shareholders, and more importantly the medical world as well.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.